Unicycive Therapeutics Inc (UNCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 0 | 0 | 675 | 951 | 0 |
| Gross Profit | N/A | N/A | 675 | 951 | N/A |
| Operating Expenses | 29,517 | 32,117 | 21,449 | 19,003 | 8,977 |
| Operating Income | -29,517 | -32,117 | -20,774 | -18,052 | -8,977 |
| Interest Expense | 71 | 71 | 82 | 6 | 628 |
| Other Income | 3,033 | -4,541 | -9,688 | 0 | -412 |
| Pre-tax Income | -26,555 | -36,729 | -30,544 | -18,058 | -10,017 |
| Net Income Continuous | -26,555 | -36,729 | -30,544 | -18,058 | -10,017 |
| Net Income | $-26,555 | $-36,729 | $-30,544 | $-18,058 | $-10,017 |
| EPS Basic Total Ops | -1.67 | -5.65 | -12.80 | -12.00 | -8.60 |
| EPS Basic Continuous Ops | -1.67 | -5.48 | -12.45 | -11.99 | -8.58 |
| EPS Diluted Total Ops | -1.67 | -5.65 | -12.80 | -12.00 | -8.60 |
| EPS Diluted Continuous Ops | -1.67 | -5.48 | -12.45 | -11.99 | -8.58 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.80 | -6.00 | -12.00 | -8.60 |
| EBITDA(a) | $-28,945 | $-31,689 | $-20,490 | $-17,891 | $-8,476 |